Basic Information
RNALocate ID: | RLID:01002590 |
RNA Symbol: | hsa-miR-30c-2-3p |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-30c-2* |
RNA ID: | miRBase:MIMAT0004550 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22984580 |
Tissue/Cell Line: | Cell line (HEK-293|HeLa) |
Method: | Next-generation RNA sequencing |
Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003647 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11003648 | Exosome | Plasma | 23663360 |
RLID:11003649 | Microvesicle | Seminal plasma | 23539611 |
RLID:11003650 | Microvesicle | Serum | 24797360 |
RLID-D:11000597 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001476 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30c-2-3p | Oral squamous cell carcinoma | MNDR-E-MI-37184 |
MNDR | hsa-miR-30c-2-3p | Large cell neuroendocrine cancer | MNDR-E-MI-37185 |
MNDR | hsa-miR-30c-2-3p | Ovarian clear cell carcinoma | MNDR-E-MI-37186 |
MNDR | hsa-miR-30c-2-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-37187 |
MNDR | hsa-miR-30c-2-3p | Lymphoma | MNDR-E-MI-37188 |
MNDR | hsa-miR-30c-2-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37189 |
MNDR | hsa-miR-30c-2-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37190 |
MNDR | hsa-miR-30c-2-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37191 |
MNDR | hsa-miR-30c-2-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37192 |
MNDR | hsa-miR-30c-2-3p | Her2-receptor positive breast cancer | MNDR-E-MI-37193 |
MNDR | hsa-miR-30c-2-3p | Prostate cancer | MNDR-E-MI-37194 |
MNDR | hsa-miR-30c-2-3p | Gastric cancer | MNDR-E-MI-37195 |
MNDR | hsa-miR-30c-2-3p | Alzheimer disease | MNDR-E-MI-37196 |
MNDR | hsa-miR-30c-2-3p | Intracranial aneurysm | MNDR-E-MI-37197 |
MNDR | hsa-miR-30c-2-3p | Bladder cancer | MNDR-E-MI-37198 |
MNDR | hsa-miR-30c-2-3p | Esophageal carcinoma | MNDR-E-MI-37199 |
MNDR | hsa-miR-30c-2-3p | Parkinson disease | MNDR-E-MI-37200 |
MNDR | hsa-miR-30c-2-3p | Breast cancer | MNDR-E-MI-37201 |
MNDR | hsa-miR-30c-2-3p | Thyroid cancer | MNDR-E-MI-37202 |
MNDR | hsa-miR-30c-2-3p | Pancreatic cancer | MNDR-E-MI-37203 |
MNDR | hsa-miR-30c-2-3p | Melanoma | MNDR-E-MI-37204 |
MNDR | hsa-miR-30c-2-3p | Rectum adenocarcinoma | MNDR-E-MI-37205 |
MNDR | hsa-miR-30c-2-3p | Nephroblastoma | MNDR-E-MI-37206 |
MNDR | hsa-miR-30c-2-3p | Colon cancer | MNDR-E-MI-37207 |
MNDR | hsa-miR-30c-2-3p | Colon adenocarcinoma | MNDR-E-MI-37208 |
MNDR | hsa-miR-30c-2-3p | Familial ovarian cancer | MNDR-E-MI-37209 |
MNDR | hsa-miR-30c-2-3p | Prostate adenocarcinoma | MNDR-E-MI-37210 |
MNDR | hsa-miR-30c-2-3p | Kidney cancer | MNDR-E-MI-37211 |
MNDR | hsa-miR-30c-2-3p | Carcinoma ductal breast | MNDR-E-MI-37212 |
MNDR | hsa-miR-30c-2-3p | Glioma | MNDR-E-MI-37213 |
MNDR | hsa-miR-30c-2-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-37214 |
MNDR | hsa-miR-30c-2-3p | Gastric adenocarcinoma | MNDR-E-MI-37215 |
MNDR | hsa-miR-30c-2-3p | Cervical squamous cell carcinoma | MNDR-E-MI-37216 |
MNDR | hsa-miR-30c-2-3p | Lung squamous cell carcinoma | MNDR-E-MI-37217 |
MNDR | hsa-miR-30c-2-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-37218 |
MNDR | hsa-miR-30c-2-3p | Lung adenocarcinoma | MNDR-E-MI-37219 |
MNDR | hsa-miR-30c-2-3p | Thyroid carcinoma | MNDR-E-MI-37220 |
MNDR | hsa-miR-30c-2-3p | Bladder urothelial carcinoma | MNDR-E-MI-37221 |
MNDR | hsa-miR-30c-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-37222 |
MNDR | hsa-miR-30c-2-3p | Carcinoma renal cell | MNDR-E-MI-37223 |
MNDR | hsa-miR-30c-2-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37224 |
MNDR | hsa-miR-30c-2-3p | Renal clear cell carcinoma | MNDR-E-MI-37225 |
MNDR | hsa-miR-30c-2-3p | Biliary tract cancer | MNDR-E-MI-37226 |
MNDR | hsa-miR-30c-2-3p | Cholangiocarcinoma | MNDR-E-MI-37227 |
MNDR | hsa-miR-30c-2-3p | Lung small cell carcinoma | MNDR-E-MI-37228 |
MNDR | hsa-miR-30c-2-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-37229 |
MNDR | hsa-miR-30c-2-3p | Breast invasive carcinoma | MNDR-E-MI-37230 |
MNDR | hsa-miR-30c-2-3p | Progressive supranuclear palsy | MNDR-E-MI-37231 |
MNDR | hsa-miR-30c-2-3p | Hepatocellular carcinoma | MNDR-E-MI-37232 |
MNDR | hsa-miR-30c-2-3p | Familiar ovarian carcinoma | MNDR-E-MI-37233 |
MNDR | hsa-miR-30c-2-3p | Skin cutaneous melanoma | MNDR-E-MI-37234 |
MNDR | hsa-miR-30c-2-3p | Skin melanoma | MNDR-E-MI-37235 |
MNDR | hsa-miR-30c-2-3p | Colorectal cancer | MNDR-E-MI-37236 |
MNDR | hsa-miR-30c-2-3p | Nasopharynx carcinoma | MNDR-E-MI-37237 |
MNDR | hsa-miR-30c-2-3p | Nasopharyngeal cancer | MNDR-E-MI-37238 |
MNDR | hsa-miR-30c-2-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37239 |
MNDR | hsa-miR-30c-2-3p | Breast cancer her3+ negative | MNDR-E-MI-37240 |
MNDR | hsa-miR-30c-2-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-37241 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ATF3 | Homo sapiens | RR00155508 |
TOP